Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease
Clinical trial NCT01150890 · TERMINATED
Trial details
- NCT number
- NCT01150890
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-09
- Primary completion
- 2011-10-15
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.